The effect of dobutamine in sepsis: a propensity score matched analysis

[1] Andrew R(2017)Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016 Intensive Care Med 43 304-377

[2] Laura EE(2015)Trial of early, goal-directed resuscitation for septic shock N Engl J Med 372 1301-1311

[3] Waleed A(2014)A randomized trial of protocol-based care for early septic shock N Engl J Med 370 1683-1693

[4] Mitchell ML(2014)Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med 371 1496-1506

[5] Massimo A(2015)Acute haemodynamic effects of dobutamine in experimental sepsis-induced myocardial depression Intensive Care Med Exp 3 A799-637

[6] Ricard F(2007)Catecholamine treatment for shock-equally good or bad? Lancet 370 636-416

[7] Mouncey PR(2016)Dobutamine induced eosinophilic cardiomyopathy JACC 67 1047-e220

[8] Osborn TM(2018)Dobutamine-induced takotsubo cardiomyopathy: a systematic review of the literature and case report Anatol J Cardiol 19 412-228

[9] Power GS(2018)Pathophysiological insights from dobutamine-induced takotsubo syndrome? Anatol J Cardiol 4 e296-810

[10] Harrison DA(2007)The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies PLOS Med 2016 160035-633

[1] Andrew R(2017)Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016 Intensive Care Med 43 304-377

[2] Laura EE(2015)Trial of early, goal-directed resuscitation for septic shock N Engl J Med 372 1301-1311

[3] Waleed A(2014)A randomized trial of protocol-based care for early septic shock N Engl J Med 370 1683-1693

[4] Mitchell ML(2014)Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med 371 1496-1506

[5] Massimo A(2015)Acute haemodynamic effects of dobutamine in experimental sepsis-induced myocardial depression Intensive Care Med Exp 3 A799-637

[6] Ricard F(2007)Catecholamine treatment for shock-equally good or bad? Lancet 370 636-416

[7] Mouncey PR(2016)Dobutamine induced eosinophilic cardiomyopathy JACC 67 1047-e220

[8] Osborn TM(2018)Dobutamine-induced takotsubo cardiomyopathy: a systematic review of the literature and case report Anatol J Cardiol 19 412-228

[9] Power GS(2018)Pathophysiological insights from dobutamine-induced takotsubo syndrome? Anatol J Cardiol 4 e296-810

[10] Harrison DA(2007)The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies PLOS Med 2016 160035-633